Knutsson Karl A, Matuska Stanislav, Rama Paolo
Department of Ophthalmology, San Raffaele Scientific Institute, Milan - Italy.
Cornea and Ocular Surface Unit, San Raffaele Scientific Institute, Milan - Italy.
Eur J Ophthalmol. 2017 Aug 30;27(5):e137-e139. doi: 10.5301/ejo.5001003.
To describe a case of unilateral limbal stem cell deficiency (LSCD) with previously failed autologous graft, resolved by ocular surface reconstruction using cultured autologous limbal stem cells from the contralateral eye.
A 35-year-old patient presented to our clinic with LSCD due to a unilateral alkali burn. The patient had received a previous limbal graft from the contralateral eye that had failed to impede corneal conjunctivalization. We decided to repeat limbal stem cell transplantation using an ex vivo cultivation procedure to reduce the risk of tissue harvesting on the healthy fellow eye. A small limbal biopsy (1.5 × 1.5 mm) near the previously excised limbus was performed. Stem cells were then isolated and cultured on fibrin and a 3T3 feeder cell layer using a standard protocol. Four months later, the cultivated cells on fibrin were grafted after pannus removal. In the subsequent months, the ocular surface stabilized and inflammation decreased. Two years later, the patient underwent large tectonic lamellar keratoplasty for severe corneal thinning involving the entire cornea, and 6 months later central penetrating keratoplasty and extracapsular cataract extraction with intraocular lens implantation and pupilloplasty was performed. Following reconstruction, the patient showed improved best-corrected vision from count fingers to 20/200 due to amblyopia, and the ocular surface was stable with a transparent corneal graft.
Ex vivo limbal stem cell transplantation is a valid technique for treating LSCD and can be utilized for treating patients who have had previous failed limbal grafts.
描述一例单侧角膜缘干细胞缺乏(LSCD)且自体移植失败的病例,该病例通过使用对侧眼培养的自体角膜缘干细胞进行眼表重建得以解决。
一名35岁患者因单侧碱烧伤就诊于我院,诊断为LSCD。该患者此前接受过对侧眼角膜缘移植,但移植失败,未能阻止角膜结膜化。我们决定采用体外培养程序重复角膜缘干细胞移植,以降低对健康对侧眼进行组织采集的风险。在先前切除角膜缘附近进行了一个小的角膜缘活检(1.5×1.5毫米)。然后按照标准方案将干细胞分离并培养在纤维蛋白和3T3饲养层细胞上。四个月后,在去除血管翳后将纤维蛋白上培养的细胞进行移植。在随后的几个月里,眼表稳定,炎症减轻。两年后,患者因累及整个角膜的严重角膜变薄接受了大型结构性板层角膜移植术,6个月后进行了中央穿透性角膜移植术、白内障囊外摘除联合人工晶状体植入术和瞳孔成形术。重建后,由于弱视,患者的最佳矫正视力从数指提高到20/200,眼表稳定,角膜移植片透明。
体外角膜缘干细胞移植是治疗LSCD的一种有效技术,可用于治疗先前角膜缘移植失败的患者。